GlassScriptPhysician profile
Jordan Shapiro
NPI 1073839239
$100,661.25
in general payments reported to CMS, 2019-2025
20 companies · $46.51 in 2025
The $46.51 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96K · 2021: $1,197 · 2022: $3,090 · 2023: $46.10 · 2024: $24.21 · 2025: $46.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $116.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $96,085.52 | 2019-2022 | |
| Mahana Therapeutics, INC. | $2,001.03 | 2022 | |
| Gi Supply, INC. | $1,050.00 | 2021 | |
| Abbvie INC. | $580.57 | 2019-2022 | |
| Celgene Corporation | $128.70 | 2022 | |
| Janssen Scientific Affairs, LLC | $121.77 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $100.58 | 2019-2022 | |
| Aries Pharmaceuticals, INC. | $100.45 | 2019 | |
| Janssen Biotech, INC. | $91.02 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $80.02 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $54.30 | 2022-2023 | Dificid |
| Dexcom, INC. | $46.51 | 2025 | Dexcom G6 Transmitter |
| Genzyme Corporation | $44.98 | 2022-2024 | |
| Qol Medical, LLC | $43.90 | 2022 | |
| Braintree Laboratories, INC. | $36.69 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $25.44 | 2022 | |
| Alexion Pharmaceuticals, INC. | $22.68 | 2022 | |
| Redhill Biopharma INC. | $15.94 | 2023 | Talicia |
| Gilead Sciences, INC. | $15.88 | 2022 | |
| Ardelyx, INC. | $15.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Shapiro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.